Lab
Sanford Bismarck
Sanford Bismarck was paid $4.25M by Medicaid between Jan 2018 and Dec 2024, across 143 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 13% of everything it billed.
33Billing provider infoSANFORD BISMARCK
BISMARCK, ND 58501
BISMARCK, ND 58501
33aNPI1154485944assigned 12/19/2006
33bProvider typeClinical Medical Laboratory
28Total paid$4.25M
24GClaims269,096
24DCodes billed143
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in North Dakota
Rank by total paid#3 of 15
Median peer was paid$4K
This provider vs. median1,051×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MORRISON, TONY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,530 | $252K | |
| 2019 | 35,884 | $632K | |
| 2020 | 39,679 | $740K | |
| 2021 | 52,391 | $931K | |
| 2022 | 47,696 | $646K | |
| 2023 | 67,809 | $928K | |
| 2024incomplete | 3,107 | $122K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 13% | 12,209 | 7,079 | $532K |
| 80053 | Comprehensive metabolic panel | 8.9% | 16,709 | 14,595 | $378K |
| 84443 | Thyroid stimulating hormone (TSH) | 5.4% | 9,721 | 9,157 | $230K |
| 88307 | 5.4% | 2,609 | 2,362 | $230K | |
| 80061 | Lipid panel | 4.0% | 9,802 | 9,313 | $172K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 3.2% | 3,640 | 3,491 | $134K |
| 88342 | 3.0% | 2,061 | 1,514 | $126K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.9% | 3,575 | 3,374 | $122K |
| 80050 | General health panel | 2.7% | 1,685 | 1,590 | $115K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 2.6% | 1,941 | 1,860 | $110K |
| 36415 | Collection of venous blood by venipuncture | 2.4% | 39,946 | 34,424 | $101K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2.2% | 11,596 | 10,211 | $96K |
131 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 12,292 | $86K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.0% | 8,604 | $85K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.9% | 2,329 | $83K |
| 86803 | 1.7% | 3,477 | $72K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.6% | 820 | $69K |
| 86850 | 1.6% | 3,626 | $68K | |
| 87150 | 1.5% | 1,811 | $65K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.3% | 4,008 | $57K |
| 82728 | 1.3% | 4,042 | $55K | |
| 82607 | 1.3% | 2,417 | $54K | |
| 88141 | 1.2% | 1,534 | $51K | |
| 86780 | 1.2% | 4,207 | $50K | |
| 87077 | 1.2% | 3,437 | $49K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.1% | 903 | $45K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.0% | 894 | $43K |
| 87186 | <1% | 4,141 | $39K | |
| 84439 | <1% | 5,593 | $36K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 405 | $34K |
| 87070 | <1% | 2,518 | $32K | |
| 83970 | <1% | 514 | $31K | |
| 81001 | <1% | 9,575 | $30K | |
| 83550 | <1% | 4,198 | $29K | |
| 80074 | <1% | 365 | $27K | |
| 88304 | <1% | 2,038 | $27K | |
| 87390 | <1% | 1,282 | $26K | |
| 87340 | <1% | 2,807 | $26K | |
| 86140 | <1% | 4,848 | $25K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 214 | $24K |
| 0240U | <1% | 134 | $23K | |
| 85027 | <1% | 3,414 | $22K | |
| 88341 | <1% | 302 | $22K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 150 | $22K |
| 87631 | <1% | 184 | $21K | |
| 82570 | <1% | 4,454 | $21K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 220 | $20K |
| 83540 | <1% | 4,314 | $20K | |
| 84702 | <1% | 1,570 | $20K | |
| 85610 | <1% | 3,629 | $19K | |
| 84165 | <1% | 1,250 | $17K | |
| 86762 | <1% | 662 | $17K | |
| 84146 | <1% | 739 | $16K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 419 | $16K |
| 82043 | <1% | 2,597 | $16K | |
| 87210 | <1% | 2,295 | $14K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 285 | $14K |
| 84153 | <1% | 273 | $13K | |
| 88112 | <1% | 297 | $12K | |
| 87147 | <1% | 1,257 | $12K | |
| 83735 | <1% | 1,766 | $11K | |
| 84403 | <1% | 355 | $11K | |
| 87522 | Neg quan hep c or qual rna | <1% | 175 | $11K |
| 80069 | <1% | 899 | $10K | |
| 87634 | <1% | 154 | $9K | |
| 88312 | <1% | 151 | $9K | |
| 80076 | <1% | 711 | $8K | |
| 87205 | <1% | 2,306 | $8K | |
| 82746 | <1% | 443 | $7K | |
| 81003 | <1% | 3,229 | $7K | |
| 83001 | <1% | 389 | $7K | |
| 86706 | <1% | 545 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 385 | $6K |
| 86900 | <1% | 2,110 | $6K | |
| 82950 | <1% | 1,198 | $6K | |
| 86901 | <1% | 2,006 | $6K | |
| 86038 | <1% | 250 | $6K | |
| 85652 | <1% | 2,517 | $6K | |
| 83880 | <1% | 145 | $5K | |
| 84156 | <1% | 1,592 | $5K | |
| 84481 | <1% | 245 | $5K | |
| 86696 | <1% | 65 | $4K | |
| 83690 | <1% | 573 | $4K | |
| 82670 | <1% | 173 | $4K | |
| 86704 | <1% | 351 | $4K | |
| 85060 | <1% | 125 | $3K | |
| 82565 | <1% | 527 | $3K | |
| 86702 | <1% | 1,302 | $3K | |
| 83516 | <1% | 120 | $3K | |
| 86334 | <1% | 206 | $3K | |
| 88311 | <1% | 398 | $3K | |
| 81015 | <1% | 797 | $3K | |
| 84100 | <1% | 476 | $2K | |
| 86701 | <1% | 1,282 | $2K | |
| 82550 | <1% | 263 | $2K | |
| 86431 | <1% | 292 | $2K | |
| 87279 | <1% | 112 | $2K | |
| 82077 | <1% | 68 | $2K | |
| 81025 | <1% | 131 | $2K | |
| 88302 | <1% | 137 | $1K | |
| 85730 | <1% | 303 | $1K | |
| 83002 | <1% | 81 | $1K | |
| 87641 | <1% | 17 | $1K | |
| 82533 | <1% | 62 | $1K | |
| 84550 | <1% | 224 | $1K | |
| 85018 | <1% | 604 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 46 | $1K |
| 86480 | <1% | 12 | $1K | |
| 87046 | <1% | 17 | $1K | |
| 82140 | <1% | 55 | $944.60 | |
| 82247 | <1% | 165 | $776.16 | |
| 88142 | <1% | 18 | $653.06 | |
| 85379 | <1% | 56 | $647.24 | |
| 82784 | <1% | 48 | $622.14 | |
| 86695 | <1% | 63 | $609.85 | |
| 87299 | <1% | 38 | $579.60 | |
| 87276 | <1% | 38 | $578.52 | |
| 82105 | <1% | 40 | $554.62 | |
| 87280 | <1% | 38 | $532.80 | |
| 87260 | <1% | 38 | $532.80 | |
| 87275 | <1% | 38 | $532.80 | |
| 87493 | <1% | 13 | $484.53 | |
| 87653 | <1% | 16 | $476.63 | |
| 86300 | <1% | 28 | $474.50 | |
| 36416 | <1% | 67 | $439.20 | |
| 86364 | <1% | 15 | $397.90 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 732 | $381.83 |
| 82378 | <1% | 15 | $303.36 | |
| 82248 | <1% | 69 | $286.31 | |
| 84144 | <1% | 14 | $219.03 | |
| 83615 | <1% | 28 | $205.36 | |
| 80164 | <1% | 17 | $176.02 | |
| 82947 | <1% | 50 | $148.29 | |
| 87328 | <1% | 14 | $147.00 | |
| 86200 | <1% | 12 | $116.12 | |
| 84703 | <1% | 12 | $104.47 | |
| 82150 | <1% | 13 | $100.44 | |
| 87427 | <1% | 18 | $95.84 | |
| 87329 | <1% | 14 | $71.88 | |
| 87045 | <1% | 17 | $66.08 | |
| 84460 | <1% | 14 | $42.40 | |
| 84450 | <1% | 13 | $41.44 | |
| G0432 | Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening | 0% | 97 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMORRISON, TONY (VICE PRESIDENT, REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Sanford Medical Center Fargo | Fargo, ND | $50.18M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $47.45M |
| Sanford Bismarck | Bismarck, ND | $43.96M |
| Sanford Health of Northern Minnesota | Bemidji, MN | $27.11M |
| Sanford Medical Center | Sioux Falls, SD | $24.40M |
| FM Ambulance Service, INC | Fargo, ND | $23.80M |
| Sanford Medical Center | Sioux Falls, SD | $18.03M |
| Sanford Health Network | Worthington, MN | $7.58M |
| Sanford Clinic | Sioux Falls, SD | $6.04M |
| Sanford Clinic | Sioux Falls, SD | $5.45M |
| Sanford Healthcare Accessories, LLC | Fargo, ND | $4.79M |
| Sanford Health Network North | Thief River Falls, MN | $3.28M |
| Sanford Clinic | Sioux Falls, SD | $2.96M |
| Sanford Health Network | Jackson, MN | $2.81M |
| Sanford Clinic | Watertown, SD | $2.02M |
| Black Hills Orthopedic & Spine Center, INC. | Rapid City, SD | $1.71M |
| Sanford Health Network | Chamberlain, SD | $1.47M |
| Sanford Health Network | Vermillion, SD | $1.31M |
| Sanford Health Network | Luverne, MN | $1.27M |
| Sanford Medical Center Fargo | Pelican Rapids, MN | $1.01M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.